HOME About IAB Bio-venture companies created from IAB
Bio-venture companies created from IAB
A number of venture companies have been created based on the results of studies conducted at IAB.
HMT is a leading metabolomics company, providing comprehensive metabolome analysis of blood, urine, cells, foods, and drinks, while developing biomarkers for early diagnosis of various diseases such as depression.
This company synthesizes and produces high-performance structural proteins like those found in spider silk, and carries out research and development to put them to practical use as next-generation biomaterials.
SalivaTech develops saliva-based tests for the detection of various diseases.
This company developed cutting-edge stool analysis technologies, which provides an evidence-based improvement of intestinal environment through adequate dietary modification to promote individual health condition toward creating a disease-free society.
Metcela, Inc. is a cutting-edge biotech startup developing new treatments for heart failure.
MOLCURE is a bio-venture company developing Abtracer™, a proprietary biopharmaceutical development platform that integrates next-generation sequencing, bioinformatics, and antibody engineering.